RxDoctor Payments Data

Lawrence Beatty, MD

Family Medicine · Johnstown, PANPI 1417906413

Payments from drug & device makers

$1,541in general payments, 2019–2025

Across 102 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$518
  • Pfizer$192
  • Lilly USA, LLC$132
  • Novo Nordisk$113
  • Johnson & Johnson$79
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$71
  • plus $436 from 15 others

What the payments were for

  • Food & beverage$1,48196%
  • Education$604%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,541 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$19,211
Medicare patients
39
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban88$66,180
JardianceEmpagliflozin20$22,168
XareltoRivaroxaban22$16,652
FarxigaDapagliflozin Propanediol16$8,515
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,113
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$6,153
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$3,284
Potassium Chloride103$2,382
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,371
Pantoprazole Sodium192$2,319
Levothyroxine Sodium173$2,302
Atorvastatin Calcium167$2,230
Albuterol Sulfate HfaAlbuterol Sulfate46$2,153
Potassium Citrate ErPotassium Citrate24$1,596
Metoprolol Succinate78$1,533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$192$66,18088 claims
Boehringer IngelheimJardiance$27$22,16820 claims
Johnson & JohnsonXarelto$79$16,65222 claims
AstraZenecaFarxiga$49$8,51516 claims
GSKTrelegy Ellipta$27$7,11311 claims
AbbVieSynthroid$518$61522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Johnstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →